chr1-19356732-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004930.5(CAPZB):c.491C>T(p.Thr164Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000093 in 1,613,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. T164T) has been classified as Likely benign.
Frequency
Consequence
NM_004930.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CAPZB | NM_004930.5 | c.491C>T | p.Thr164Ile | missense_variant | 6/9 | ENST00000264202.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CAPZB | ENST00000264202.8 | c.491C>T | p.Thr164Ile | missense_variant | 6/9 | 1 | NM_004930.5 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249340Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135288
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461296Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 727006
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 31, 2023 | The c.491C>T (p.T164I) alteration is located in exon 6 (coding exon 6) of the CAPZB gene. This alteration results from a C to T substitution at nucleotide position 491, causing the threonine (T) at amino acid position 164 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at